A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With Kawasaki Disease

Completed · Phase 3

Conditions studied: Kawasaki Disease

In brief

Determine the predictive value of CARDIOLITE® rest and stress myocardial perfusion imaging (MPI) to define a pediatric population with Kawasaki Disease (KD) at high and low risk of developing cardiac events.

Key facts

Study ID

NCT00162032

Run by

Lantheus Medical Imaging

People needed

445

Starts

2005-08-01

Expected to finish

2010-12-01

Last updated by the study team

2019-07-23

Who can join

Age: 4 and older, up to 16. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Males or females between 4 and 16
• Meet the epidemiological definition of Kawasaki Disease or have a diagnosis of incomplete KD, including evidence of coronary artery disease as determined by their physician.
• Be able to exercise adequately to achieve 85% age predicted maximum heart rate

You may not qualify if…

• Terminal illness where expected survival is < 6 months

Where it is running

• Local Institution — Anchorage, Alaska, United States
• Local Institution — Little Rock, Arkansas, United States
• Local Institution — Los Angeles, California, United States
• Local Institution — Orange, California, United States
• Local Institution — San Diego, California, United States
• Local Institution — Denver, Colorado, United States
• Local Institution — Hartford, Connecticut, United States
• Local Institution — New Haven, Connecticut, United States
• Local Institution — Honolulu, Hawaii, United States
• Local Institution — Chicago, Illinois, United States
• Local Institution — Chicago, Illinois, United States
• Local Institution — Park Ridge, Illinois, United States
• Local Institution — Indianapolis, Indiana, United States
• Local Institution — Lexington, Kentucky, United States
• Local Institution — Boston, Massachusetts, United States
• Local Institution — Las Vegas, Nevada, United States
• Local Institution — New Hyde Park, New York, United States
• Local Institution — New York, New York, United States
• Local Institution — Durham, North Carolina, United States
• Local Institution — Greenville, North Carolina, United States
• Local Institution — Cincinnati, Ohio, United States
• Local Institution — Cleveland, Ohio, United States
• Local Institution — Hershey, Pennsylvania, United States
• Local Institution — Philadelphia, Pennsylvania, United States
• Local Institution — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.